A12 The SHP2 Inhibitor RMC-4630 in Patients with KRAS-Mutant Non-Small Cell Lung Cancer: Preliminary Evaluation of a First-in-Man Phase 1 Clinical Trial
暂无分享，去创建一个
P. Jänne | J. Riess | S. Ou | Aileen B Chen | H. Burris | E. Haura | T. Bivona | J. Hayes | A. Capasso | M. Gordon | K. Ng | C. McCoach | S. Eckhardt | R. Nichols | J. Pacheco | M. Koczywas | J. S. Wang | S. Ulahannan | Z. Wang | V. Zhu | R. Dua